文献速递胃肠动力与功能性疾病消化内镜

结肠镜检查后肠易激综合征风险与抗生素暴露的关系:回顾性队列研究

Risk for Post-Colonoscopy Irritable Bowel Syndrome in Patients With and Without Antibiotic Exposure: A Retrospective Cohort Study.
PubMed 文献 · Clin Gastroenterol Hepatol · 2021-09-03

该回顾性队列研究基于美国Optum数据库,纳入50-55岁接受筛查性结肠镜检查的个体,比较结肠镜检查前后14天内暴露于抗生素者与倾向评分匹配的未暴露者。结果显示抗生素使用与新发IBS诊断无显著关联(HR 1.11;95%CI 0.89-1.39),但与复合结局(IBS诊断、药物或症状)存在弱关联(HR 1.12;95%CI 1.02-1.24;NNH=94)。

要点

  • 结肠镜围术期抗生素暴露与新发IBS诊断无显著统计学关联。
  • 抗生素暴露与IBS复合结局(诊断、药物或症状)存在弱关联,NNH为94。
  • 需谨慎解读复合结局的弱关联,避免过度归因于抗生素。

核心结论

  • 结肠镜检查时同时暴露于抗生素和肠道清洁剂者,其替代IBS结局的发生率略高于未同时使用抗生素的匹配对照。

研究设计与样本

  • 回顾性队列研究,使用美国Optum去标识化Clinformatics Data Mart数据库,纳入50-55岁接受筛查性结肠镜检查的个体408,714例。
  • 将结肠镜检查前后14天内暴露于抗生素的24,617例(6.0%)与倾向评分匹配的24,617例未暴露者进行比较。
  • 主要结局为新发IBS诊断,复合结局为新索赔的IBS、IBS药物或IBS症状;采用Cox比例风险回归分析关联。

主要发现

  • 抗生素使用与新发IBS诊断无显著统计学关联(HR 1.11;95%CI 0.89-1.39)。
  • 抗生素使用与复合结局存在弱关联(HR 1.12;95%CI 1.02-1.24;NNH=94)。

临床怎么用

  • 对于接受筛查性结肠镜检查的患者,围术期抗生素暴露与新发IBS诊断风险无显著增加,但复合IBS结局风险轻度升高,临床可据此评估风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Laboratory studies have demonstrated that antibiotic use in conjunction with bowel purgatives causes alterations to the gut microbiota. Because gut microbiota changes may be a trigger for the development of irritable bowel syndrome (IBS), we sought to assess whether individuals who undergo bowel cleansing for colonoscopy and have concurrent antibiotic exposure develop IBS at higher rates than individuals who undergo colonoscopy without antibiotic exposure. METHODS: We used data from Optum's de-identified Clinformatics Data Mart Database in the United States to study a cohort of 50- to 55-year-olds who underwent screening colonoscopy. Individuals exposed to antibiotics within 14 days of colonoscopy were propensity-score matched to individuals who were not exposed to antibiotics around colonoscopy. The primary outcome was a new IBS diagnosis, and the composite outcome was a new claim for IBS, IBS medications, or IBS symptoms. The association of antibiotic exposure and the outcomes was calculated using Cox proportional hazards regression. RESULTS: There were 408,714 individuals who met criteria for the screening colonoscopy cohort. Of these, 24,617 (6.0%) were exposed to antibiotics around the time of colonoscopy, and they were propensity-score matched to 24,617 individuals not exposed to antibiotics. There was no statistically significant association between antibiotic use and IBS (hazard ratio, 1.11; 95% confidence interval, 0.89-1.39), but there was a weak association between antibiotic use and the composite outcome (hazard ratio, 1.12; 95% confidence interval, 1.02-1.24; number needed to harm, 94). CONCLUSIONS: Individuals concurrently exposed to antibiotics and bowel purgative had slightly higher rates of surrogate IBS outcomes compared with matched controls who did not receive antibiotics concurrently with bowel purgative.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Vajravelu RK, Shapiro JM, Ni J, et al. Risk for Post-Colonoscopy Irritable Bowel Syndrome in Patients With and Without Antibiotic Exposure: A Retrospective Cohort Study. Clin Gastroenterol Hepatol. 2021. PMID: 34481956. doi:10.1016/j.cgh.2021.08.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。